Radiotherapeutic options for symptom control in breast cancer

Breast Care

Volumn 6, Issue 1, 2011, Pages 14-19

  Van Oorschot, Birgitt ^a   Beckmann, Gabriele ^a   Schulze, Wolfgang ^b   Rades, Dirk ^c   Feyer, Petra ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Clinical Center Bayreuth   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d Medical Department III (Hematology Oncology)   (Germany)

Author keywords

Breast cancer; Palliative care; Radiotherapy; Symptom control

Indexed keywords

ANALGESIC AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CAPECITABINE; CORTICOSTEROID; DEXAMETHASONE;

ADVANCED CANCER; ANALGESIA; BONE METASTASIS; BONE PAIN; BRAIN METASTASIS; BRAIN SURGERY; BREAST CANCER; BREAST HEMORRHAGE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMATOUS MENINGITIS; CORTICOSTEROID THERAPY; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; METASTATIC SPINAL CORD COMPRESSION; MULTIMODALITY CANCER THERAPY; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; PATIENT ASSESSMENT; PATIENT DECISION MAKING; PATIENT INFORMATION; PRIORITY JOURNAL; RADIOSURGERY; REVIEW; SOFT TISSUE METASTASIS; SPINAL CORD COMPRESSION; ULCER;

EID: 79952269116     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000324564     Document Type: Review

References (50)

1. AWMF-Leitlinie «Diagnostik, Therapie und Nachsorge des Mammakarzinoms der Frau» Stand 4/2008, www.uni-duesseldorf.de/awmf/ll/ll- 077.htm .
2. Thomssen C, Harbeck N; on behalf of the AGO: Update 2010 of the German AGO recommendations for the diagnosis and treatment of early and metastatic breast cancer: chapter B: prevention, early detection, lifestyle, premalignant lesions, DCIS, recurrent and metastatic breast cancer. Breast Care 2010;5:345-351.
3. Souchon R, Wenz F, Sedlmayer F, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sautter-Bihl M, Sauer R: DEGRO Practical Guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression. Strahlenther Onkol 2009;7:417-424.
4. Feyer P, Sautter-Bihl ML, Budach W, Dunst J, Haase W, Harms W, Sedlmayer F, Souchon R, Wenz F, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO): DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol 2010;186:63-69.
5. Coleman RE: Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:6243-6249.
6. Clemons M, Dranitsaris G, Cole D, Gainford MC: Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer. Oncologist 2006;11:227-233.
7. Janjan N, Lutz ST, Bedwinek LM, Hartsell WF, Ng A, Pieters RS Jr, Ratanatharathorn V, Silberstein EB, Taub RJ, Yasko AW, Rettenmaier A: Therapeutic guidelines for the treatment of bone metastasis: a report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. J Palliat Med 2009;12:417- 426.
8. Rades D: Dose-fractionation schedules for radiotherapy of bone metastases. Breast Care 2010;5: 339-344.
9. Niewald M, Tkocz HJ, Abel U, Scheib T, Walter K, Nieder C, Schnabel K, Berberich W, Kubale R, Fuchs M: Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys 1996;36:1085-1089. (Pubitemid 27014494)
10. Roos DE, Turner SL, O'Brian PC, Smith JG, Spry NA, Burmeister BH, Hoskin PJ, Ball DL, Trans-Trasman Radiation Oncology Group, TROG 96.05: Randomized trial of 8Gy in 1 versus 20Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases. Radiother Oncol 2005;71:54-63. (Pubitemid 40616795)
11. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605. (Pubitemid 36170000)
12. Sze WM, Shelley M, Held I, Mason M: Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomized trials. Cochrane Database Syst Rev 2004(2):CD004721.
13. Van der Linden YM, Lok JJ, Steenland E, Martijn H, van Houwelingen H, Marijnen CA, Leer JW: Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 2004;59:528-537. (Pubitemid 38622611)
14. Koswig S, Budach V: Remineralisation und Schmerzlinderung von Knochenmetastasen nach unterschiedlich fraktionierter Strahlentherapie (10×3 Gy vs. 1×8 Gy). Strahlenther Onkol 1999;175:500-508. (Pubitemid 29491375)
15. Rades D, Heidenreich F, Karstens JH: Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2002;53:975-979. (Pubitemid 34722644)
16. Tang V, Harvey D, Park Dorsay J, Jiang S, Rathbone MP: Prognostic indicators in metastatic spinal cord compression: using functional independence measure and Tokuhashi scale to optimize rehabilitation planning. Spinal Cord 2007;45:671-677. (Pubitemid 47530648)
17. Patchell RA, Tibbs PA, Regine WF, Tibbs PA, Wilson D, Shappley D, Young BY: Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial Lancet 2005;366:643-648. (Pubitemid 41176016)
18. Rades D, Stalpers LJ, Hulshof MC, Zschenker O, Alberti W, Koning CC: Comparison of 1×8 Gy and 10×3 Gy for functional outcome in patients with metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2005;62:514-518. (Pubitemid 40704470)
19. Maranzano E, Latini P, Checcaglini F, Perrucci E, Aristei C, Panizza BM, Ricci S: Radiation therapy of spinal cord compression caused by breast cancer: report of a prospective trial. Int J Radiat Oncol Biol Phys 1992;24:301-306.
20. Rades D, Abrahm JL: The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol 2010;7:590-598.
21. Lai R, Dang CT, Malkin MG, Abrey LE: The risk of central nervous metastases after trastuzumab therapy in patients with breast carcinoma. Cancer 2004;10:810-816. (Pubitemid 39030939)
22. Mahmoud-Ahmed AS, Suh JH, Lee SY, Crownover RL, Barnett GH: Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys 2002;54:810-817.
23. Lentzsch S, Reichardt P, Weber F, Budach V, Dörken B: Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer 1999;35:580-585. (Pubitemid 29192966)
24. Mizutani Y, Yamashita T, Sakamoto G: Radiation therapy for brain metastases from breast cancer by histological classification. Nippon Igaku Hoshasen Gakkai Zasshi 2001;61:89-95.
25. Fokstuen T, Wilking N, Rutqvist LE, Wolke J; Liedberg A: Radiation therapy in the management of brain metastases from breast cancer. Breast Cancer Res and Treat 2000;62:211-216.
26. Rades D, Dunst J, Schild SE: A new scoring system to predict the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008;184:251-255. (Pubitemid 351572841)
27. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W: A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510-514.
28. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys1997;37:745-751. (Pubitemid 27181303)
29. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J; Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004;363:1665-1672. (Pubitemid 38670323)
30. Kirsch D, Loeffler JS: Brain metastases in patients with breast cancer: new horizons. Clin Breast Cancer 2005;6:115-124. (Pubitemid 40975607)
31. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC: Stereotactic radiosurgery plus whole brain radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427-434. (Pubitemid 29408559)
32. Sanghavi SN, Miranpuri SS, Chappell R, Buatti JM, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Mabanta S, Mehta MP: Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001;51:426-434. (Pubitemid 32884288)
33. Noordijk EM, Vecht CJ, Haaxma-Reiche H, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR: The choice of treatment of a single brain metastasis should be based on extracranial tumor activity and age. Int J Radia Oncol Biol Phys 1994;29:711-717. (Pubitemid 24241310)
34. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999;43:795-803. (Pubitemid 29152652)
35. Glanzmann C: Palliative Radiotherapie von Hirnmetastasen solider Tumoren: Erfahrungen mit hohen Dosen. Strahlenther Onkol 1990;166:119- 124.
36. Wong J, Hird A, Kirou-Mauro A, Napolskikh J, Chow E: Quality of life in brain metastases radiation trials: a literature review. Curr Oncol 2008;15:25-45.
37. Chow E, Davis L, Holden L, Fung KW, Schueller T, Wong R, Hayter C, Szumacher E, Loblaw A, Danjoux C: Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manage 2005;30:18-23. (Pubitemid 41021675)
38. Steinmann D, Schäfer C, van Oorschot B, Wypior HJ, Bruns F, Bölling T, Sehlen S, Hagg J, Bayerl A, Geinitz H, Hipp M, Vordermark D: Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther Onkol 2009;185:190-197.
39. Wasserstrom WR, Glass JP, Possner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759-772. (Pubitemid 12165435)
40. De Angelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998;38:245-252. (Pubitemid 28306215)
41. Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL: The results or radiation therapy for isolated regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 1991;21:299-310.
42. Buchholz T: Breast cancer: locally advanced and recurrent disease, postmastectomy radiation and systemic therapy; in Halperin EC, Perez CA, Brady LW (eds): Principles and Practice of Radiation Oncology. Philadelphia, PA, Lippincott Williams&Wilkins, 2007, pp. 1292-1316.
43. Newman LA, Hunt KK, Buchholz T, Kuerrer HM, Vlastos G, Mirza N, Ames FC, Ross MI, Singletary SE: Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 2000;180:252-256.
44. Aberizk WJ, Silver B, Henderson IC, Cady B, Harris JR: The use or radiotherapy for treatment of isolated loco-regional recurrence of breast carcinoma after mastectomy. Cancer 1986;58:1214-1218. (Pubitemid 16053131)
45. Herfarth KK, Debus J, Lohr F, Bahner ML, Wannenmacher M: Stereotactic irradiation of liver metastases. Radiologe 2001;41:64-68.
46. Greco C, Catalano G, Di Grazia A, Orecchia R: Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic hypofractionated radiotherapy. Tumori 2004;90:73-79. (Pubitemid 38541731)
47. Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, Flentje M: Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006;45:838-847. (Pubitemid 44423130)
48. Swaminath A, Dawson LA: Emerging role of radiotherapy in the management of liver metastases. Cancer J 2010;16:150-155.
49. Combs SE, Herfarth KK, Habermehl D, Debus J: (Radiotherapy of hepatic metastases). Chirurg 2010;81:526-532.
50. Borgelt BB, Gelber R, Brady LW, Griffin T, Hendrickson FR: The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 1981;7:587-559.